See it. Believe it. Treat it.

Order Nuclear Medicine Week merch early!
Sept 13 is the deadline to order NMW merchandise for arrival by Oct 4. Please order early!

Shop Now!

SNMMI News Explore All News

Peptide Receptor Radionuclide Therapy...Treats Metastatic Neuroendocrine Tumors

Among treatments for metastatic neuroendocrine tumors, peptide receptor radionuclide therapy (PRRT) is the most effective and least toxic, according to new research published in the September issue of The Journal of Nuclear Medicine.

SNMMI Sponsors ICPO Theranostics Summit 2024

SNMMI is proud to sponsor this year's ICPO virtual summit, highlighting a new era in theranostics.

SNMMI Submits Comments Supporting the Unpackaging of Diagnostic Pharmaceuticals

SNMMI has submitted comments in support of unbundling diagnostic radiopharmaceuticals in response to CMS' CY2025 Outpatient Prospective Payment System (OPPS) Proposed Rule.

2024 SNMMI Therapeutics Conference - Bethesda, MD

EXPLORE THE LATEST IN RADIOPHARMACEUTICAL THERAPY

This much anticipated event brings together leaders in radiopharmaceutical therapy to explore the latest advancements and provide valuable insights into enhancing the practice of radiopharmaceutical therapies. Don’t miss it!

Learn More

Latest Journals